Total debt rose from $297.9M at year-end 2024 to $696.0M in Q3 2026 and debt-to-equity increased from 0.15 to 0.38, indicating a shift toward debt-funded capitalization that investors should monitor.
Innovative Industrial Properties, Inc. (IIPR) balance sheet — 10-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 |
|---|
| Total Assets | 2.65B | 2.37B | 2.38B | 2.39B | 2.41B | 2.08B | 1.77B | 745.86M | 281.47M | 80.03M | 63.33M |
| Asset Growth % | 26.84% | -0.3% | -0.55% | -0.98% | 15.84% | 17.9% | 137.05% | 164.99% | 251.71% | 26.37% | - |
| Real Estate & Other Assets | 103.53M | -2.29B | 2.2B | 2.2B | 2.1B | 1.65B | 1.02B | 507.74M | 147.97M | 68.27M | 30.05M |
| PP&E (Net) | 1.98B | 509K | 946K | 1.35M | 1.74M | 1.07M | 980K | 1.2M | 0 | 0 | 0 |
| Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 |
| Total Current Assets | 145.26M | 47.6M | 169.04M | 163.7M | 106.59M | 99.33M | 126.01M | 117.32M | 13.05M | 11.76M | 33.28M |
| Cash & Equivalents | 142.35M | 47.6M | 146.25M | 140.25M | 87.12M | 81.1M | 126.01M | 82.24M | 13.05M | 11.76M | 33M |
| Receivables | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.91M | -16.8M | 0 | 1.45M | 1.45M | 5.32M | 0 | 35.07M | 0 | -482K | 0 |
| Intangible Assets | 3.73M | 6.37M | 7.38M | 8.24M | 9.11M | 9.15M | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 820.23M | 522.85M | 441.99M | 438.12M | 452.94M | 472.9M | 243.11M | 197.85M | 17.17M | 6.48M | 2.89M |
| Total Debt | 695.96M | 393.7M | 297.87M | 300.88M | 301.5M | 326.09M | 137.75M | 135.86M | 0 | 0 | 0 |
| Net Debt | 553.61M | 346.1M | 151.62M | 160.63M | 214.37M | 245M | 11.74M | 53.61M | -13.05M | -11.76M | -33M |
| Long-Term Debt | 695.96M | 74.41M | 297.87M | 300.88M | 301.5M | 326.09M | 136.69M | 134.65M | 0 | 0 | 0 |
| Short-Term Borrowings | 0 | 319.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 27K | 27K | 0 | 0 | 0 | 0 | 1.06M | 1.2M | 0 | 0 | 0 |
| Total Current Liabilities | 111.2M | 319.26M | 132.78M | 132.18M | 149.55M | 145.64M | 105.36M | 61.99M | 17.17M | 6.44M | 2.61M |
| Accounts Payable | 13.36M | 13.83M | 20.79M | 21M | 39.99M | 53.99M | 41.14M | 28.39M | 4.4M | 1.08M | 70K |
| Deferred Revenue | 0 | 50.31M | 57.18M | 59.36M | 58.72M | 52.8M | 34.15M | 20.63M | 9.01M | 4.16M | 2.54M |
| Other Liabilities | 13.08M | 129.18M | 11.34M | 5.06M | 1.9M | 1.17M | -34.15M | -20.63M | -9.01M | -4.12M | -2.27M |
| Total Equity | 1.83B | 1.85B | 1.94B | 1.95B | 1.96B | 1.61B | 1.52B | 548.01M | 264.29M | 73.55M | 60.44M |
| Equity Growth % | -9.28% | -4.55% | -0.87% | -0.45% | 21.73% | 5.69% | 178.27% | 107.35% | 259.34% | 21.69% | - |
| Shareholders Equity | 1.83B | 1.85B | 1.94B | 1.95B | 1.96B | 1.61B | 1.52B | 548.01M | 264.29M | 73.55M | 60.44M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 28K | 28K | 28K | 28K | 28K | 26K | 24K | 13K | 10K | 4K | 3K |
| Additional Paid-in Capital | 2.08B | 2.11B | 2.12B | 2.1B | 2.07B | 1.67B | 1.56B | 553.93M | 260.54M | 64M | 64.83M |
| Retained Earnings | -374.16M | -312.99M | -211.71M | -156.85M | -117.39M | -75.22M | -48.12M | -19.94M | -10.27M | -4.46M | -4.39M |
| Preferred Stock | 129M | 47.78M | 23.63M | 14.01M | 14.01M | 14.01M | 14.01M | 14.01M | 14.01M | 14.01M | 0 |
| Return on Assets (ROA) | 5.62% | 4.82% | 6.78% | 6.89% | 6.86% | 5.92% | 5.23% | 4.57% | 3.86% | -0.1% | -6.94% |
| Return on Equity (ROE) | 7.56% | 6.05% | 8.31% | 8.46% | 8.64% | 7.27% | 6.34% | 5.78% | 4.14% | -0.11% | -7.27% |
| Debt / Assets | 26.26% | 16.61% | 12.53% | 12.58% | 12.49% | 15.64% | 7.79% | 18.21% | - | - | - |
| Debt / Equity | 0.38x | 0.21x | 0.15x | 0.15x | 0.15x | 0.20x | 0.09x | 0.25x | - | - | - |
| Net Debt / EBITDA | 2.62x | 1.75x | 0.63x | 0.66x | 0.93x | 1.38x | 0.12x | 1.60x | -1.64x | -16.99x | - |
| Book Value per Share | 65.46 | 65.12 | 67.86 | 69.12 | 70.92 | 61.37 | 77.97 | 51.29 | 36.27 | 21.79 | 62.78 |
Quick answers to the most common questions about buying IIPR stock.
As of 2025, Innovative Industrial Properties, Inc. (IIPR) had total assets of $2.37B including $47.6M in current assets.
Innovative Industrial Properties, Inc. (IIPR) carries total debt of $393.7M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Innovative Industrial Properties, Inc. (IIPR) has total shareholders' equity (book value) of $1.85B ($65.12 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Innovative Industrial Properties, Inc. (IIPR) reported a current ratio of 0.15x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Cannabis tenant credit stress
Metrics are mathematically derived from official filings.
Balance Sheet Shrinking Toward Lower Leverage
As reported in the quarterly balance sheets, IIPR's total assets stayed near $2.4B to $2.7B while total debt rose from $289.5M in Q1 2025 to $696.0M in Q3 2026, shifting capitalization toward debt-funded growth.
The reported debt increase against broadly flat total assets suggests the company is funding its recent IQHQ-related deployment with borrowings rather than through asset expansion alone. Debt-to-equity rising from roughly 0.15 to 0.38 indicates leverage is building from a very low base, which may warrant monitoring of whether the new capital is generating accretive rent. Investors should track whether the trajectory reflects a deliberate repositioning or a response to weakening cannabis-tenant cash flows.
Cannabis Concentration Drives Asset Quality Risk
Based on reported figures, IIPR's net PP&E fell from roughly $2.0B-scale reporting to nil in Q1 2026, a presentation shift that appears linked to reclassification rather than a clean disposal record.
The recorded PP&E swings, including a reported zero balance in Q1 2026 alongside $2.0B in Q3 2026, make the underlying asset classification difficult to verify from the supplied data alone. The 13.8% year-over-year revenue decline is consistent with tenant stress across the legacy cannabis portfolio. This warrants further investigation into occupancy, rent collection, and the pace at which non-performing assets are being re-tenanted or reclassified.
Debt Expansion Outpaces Equity Base
Total debt climbed from $297.9M at year-end 2024 to $696.0M in Q3 2026, lifting the reported debt-to-equity ratio from 0.15 to 0.38 as equity remained near $1.8B to $1.9B.
The reported liability growth to $820.2M in Q3 2026 indicates the company has materially increased its borrowing while retaining a still-moderate leverage profile by absolute measures. The data does not disclose the maturity ladder, secured versus unsecured mix, or floating-rate exposure, so the refinancing risk cannot be fully assessed. Analysts should examine these terms in the debt footnotes before drawing firm conclusions about financing flexibility.
Cash Buffer Thins as Debt Rises
As reported in the quarterly data, IIPR's cash balance swung from $204.7M in Q2 2026 to $142.4M in Q3 2026, and was $47.6M at Q4 2025, indicating a volatile liquidity position.
The fluctuating cash balance alongside rising debt suggests liquidity is being actively deployed rather than accumulated, which may reduce the buffer available for tenant-driven shocks. Fixed charge coverage and revolver headroom are not disclosed in the supplied data, limiting assessment of covenant risk. Investors should monitor whether debt draws are sustaining the dividend, given AFFO coverage of roughly 1.03 times in the latest quarter.
Earnings Strength Versus Asset Impairment Risk
Based on reported figures, NOI collapsed from $56.7M in Q3 2025 to $21.6M in Q4 2025 on near-unchanged revenue, a pattern that may indicate non-recurring property charges masking underlying asset weakness.
The sharp NOI deterioration without a matching revenue decline points to property-level cost or impairment items rather than lost rent alone, which the balance sheet alone cannot confirm. If such charges reflect write-downs of cannabis-exposed assets, reported equity and asset values could be overstated relative to economic reality. This warrants further investigation into impairment disclosures before relying on the reported balance sheet strength.